Clinical trial
Trial of Curcumin in Advanced Pancreatic Cancer
NCT00094445 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00094445 |
|---|---|
| Title | Trial of Curcumin in Advanced Pancreatic Cancer |
| Official title | Phase II Trial of Curcumin in Patients With Advanced Pancreatic Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Sabinsa Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Neoplasms, Adenocarcinoma |
| Intervention type | Drug |
| Interventions | Curcumin |
| Enrollment | 50 |
| Start date | Nov 1, 2004 |
| Primary completion | Apr 1, 2014 |
| Completion | Apr 1, 2014 |
| First posted | Oct 19, 2004 |
| Last update posted | Aug 28, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: